Steve Cutler, Icon CEO (Icon)
In the biggest CRO takeover in years, Icon doles out $12B for PRA Health Sciences to focus on decentralized clinical work
Contract research M&A had a healthy run in recent years before recently petering out. But with the market ripe for a big buyout and the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
